|
ATE348163T1
(de)
|
1998-10-23 |
2007-01-15 |
Amgen Inc |
Thrombopoietin substitute
|
|
TWI329129B
(en)
|
2001-02-08 |
2010-08-21 |
Wyeth Corp |
Modified and stabilized gdf propeptides and uses thereof
|
|
US7320789B2
(en)
|
2001-09-26 |
2008-01-22 |
Wyeth |
Antibody inhibitors of GDF-8 and uses thereof
|
|
PL374966A1
(en)
|
2002-02-21 |
2005-11-14 |
Wyeth |
Follistatin domain containing proteins
|
|
BR0307907A2
(pt)
|
2002-02-21 |
2011-07-05 |
Wyeth Corp |
gasp1: proteìna contendo domìnio de folistatina
|
|
US7193069B2
(en)
*
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
|
AU2003267246A1
(en)
*
|
2002-09-16 |
2004-04-30 |
The Johns Hopkins University |
Metalloprotease activation of myostatin, and methods of modulating myostatin activity
|
|
US7261893B2
(en)
*
|
2002-10-22 |
2007-08-28 |
Wyeth |
Neutralizing antibodies against GDF-8 and uses therefor
|
|
US20040223966A1
(en)
*
|
2002-10-25 |
2004-11-11 |
Wolfman Neil M. |
ActRIIB fusion polypeptides and uses therefor
|
|
AU2003301195B2
(en)
*
|
2002-12-20 |
2010-01-07 |
Amgen Inc. |
Binding agents which inhibit myostatin
|
|
WO2004108157A2
(en)
|
2003-06-02 |
2004-12-16 |
Wyeth |
Use of myostatin (gdf8) inhibitors in conjunction with corticosteroids for treating neuromuscular disorders
|
|
BRPI0406605B8
(pt)
|
2003-11-13 |
2021-05-25 |
Hanmi Holdings Co Ltd |
conjugado de proteína, método para a preparação do mesmo e composição farmacêutica para intensificar a duração e estabilidade in vivo de um polipeptídeo fisiologicamente ativo
|
|
US8110665B2
(en)
|
2003-11-13 |
2012-02-07 |
Hanmi Holdings Co., Ltd. |
Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
|
|
WO2005066204A2
(en)
|
2003-12-31 |
2005-07-21 |
Schering-Plough Ltd. |
Neutralizing epitope-based growth enhancing vaccine
|
|
US9045553B2
(en)
|
2004-05-27 |
2015-06-02 |
Acceleron Pharma, Inc. |
Cerberus/Coco derivatives and uses thereof
|
|
EP1755648A2
(en)
*
|
2004-05-27 |
2007-02-28 |
Acceleron Pharma Inc. |
Cerberus/coco derivatives and uses thereof
|
|
EP1773400A2
(en)
*
|
2004-07-08 |
2007-04-18 |
Amgen Inc. |
Therapeutic peptides
|
|
CA2580796C
(en)
*
|
2004-09-24 |
2013-03-26 |
Amgen Inc. |
Modified fc molecules having peptides inserted in internal loop regions
|
|
MX2007008132A
(es)
|
2004-12-30 |
2007-07-20 |
Schering Plough Ltd |
Vacuna para aumentar el crecimiento basada en epitopes neutralizantes.
|
|
NZ538097A
(en)
*
|
2005-02-07 |
2006-07-28 |
Ovita Ltd |
Method and compositions for improving wound healing
|
|
EP1864139A2
(en)
*
|
2005-03-23 |
2007-12-12 |
Wyeth |
Detection of an immune response to gdf-8 modulating agents
|
|
MX2007011400A
(es)
*
|
2005-03-23 |
2007-10-11 |
Wyeth Corp |
Deteccion de agentes moduladores de crecimiento y la diferenciacion del factor 8 (gdf 8).
|
|
JP2008543839A
(ja)
|
2005-06-14 |
2008-12-04 |
アムジェン インコーポレーテッド |
自己緩衝タンパク質製剤
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
KR101135220B1
(ko)
*
|
2005-10-06 |
2012-04-24 |
일라이 릴리 앤드 캄파니 |
항-마이오스타틴 항체
|
|
UA92504C2
(en)
*
|
2005-10-12 |
2010-11-10 |
Эли Лилли Энд Компани |
Anti-myostatin monoclonal antibody
|
|
US20090163579A1
(en)
*
|
2005-10-14 |
2009-06-25 |
Daniel Raederstorff |
Novel use of nutraceutical compositions
|
|
US8067562B2
(en)
|
2005-11-01 |
2011-11-29 |
Amgen Inc. |
Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
|
|
US20070149458A1
(en)
*
|
2005-12-06 |
2007-06-28 |
Amgen Inc. |
Uses of myostatin antagonists
|
|
US9283260B2
(en)
|
2006-04-21 |
2016-03-15 |
Amgen Inc. |
Lyophilized therapeutic peptibody formulations
|
|
HRP20130320T1
(en)
|
2006-09-05 |
2013-05-31 |
Eli Lilly And Company |
Anti-myostatin antibodies
|
|
WO2008051383A2
(en)
*
|
2006-10-19 |
2008-05-02 |
Amgen Inc. |
Use of alcohol co-solvents to improve pegylation reaction yields
|
|
JP2010512326A
(ja)
*
|
2006-12-08 |
2010-04-22 |
アクセルロン ファーマ， インコーポレイテッド |
Ｃｅｒｂｅｒｕｓ、Ｃｏｃｏおよびこれらの誘導体の使用
|
|
US9610327B2
(en)
|
2007-03-06 |
2017-04-04 |
Amgen Inc. |
Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof
|
|
TW201718635A
(zh)
|
2007-03-06 |
2017-06-01 |
安美基公司 |
變異之活動素受體多肽及其用途
|
|
US8501678B2
(en)
|
2007-03-06 |
2013-08-06 |
Atara Biotherapeutics, Inc. |
Variant activin receptor polypeptides and uses thereof
|
|
MX2009012609A
(es)
|
2007-05-22 |
2009-12-07 |
Amgen Inc |
Composiciones y metodos para producir proteinas de fusion bioactivas.
|
|
WO2009015345A1
(en)
*
|
2007-07-25 |
2009-01-29 |
Amgen Inc. |
Pharmaceutical compositions comprising fc fusion proteins
|
|
AU2008285289A1
(en)
|
2007-08-03 |
2009-02-12 |
Biomarin Iga Limited |
Drug combinations for the treatment of Duchenne muscular dystrophy
|
|
GB0715087D0
(en)
|
2007-08-03 |
2007-09-12 |
Summit Corp Plc |
Drug combinations for the treatment of duchenne muscular dystrophy
|
|
AU2008293425B2
(en)
*
|
2007-08-31 |
2014-09-18 |
Amgen Inc. |
Solid-state protein formulation
|
|
AU2008304111B2
(en)
|
2007-09-27 |
2014-04-24 |
Amgen Inc. |
Pharmaceutical formulations
|
|
US8796206B2
(en)
|
2007-11-15 |
2014-08-05 |
Amgen Inc. |
Aqueous formulation of erythropoiesis stimulating protein stabilised by antioxidants for parenteral administration
|
|
EP2303311B1
(en)
|
2008-05-14 |
2018-08-01 |
Agriculture Victoria Services Pty Ltd |
Angiogenin for use in treating skeletal muscle disorders
|
|
PE20150680A1
(es)
|
2008-11-26 |
2015-05-16 |
Amgen Inc |
Variantes de polipeptidos receptores de activina iib y aplicaciones de estos
|
|
SG176963A1
(en)
*
|
2009-06-22 |
2012-02-28 |
Amgen Inc |
Refolding proteins using a chemically controlled redox state
|
|
US8945511B2
(en)
*
|
2009-06-25 |
2015-02-03 |
Paul Weinberger |
Sensitive methods for detecting the presence of cancer associated with the over-expression of galectin-3 using biomarkers derived from galectin-3
|
|
LT3660032T
(lt)
|
2009-06-25 |
2026-02-25 |
Amgen Inc. |
Ne žinduolių sistemoje ekspresuotų baltymų surišamojo gryninimo būdai
|
|
US9662271B2
(en)
|
2009-10-23 |
2017-05-30 |
Amgen Inc. |
Vial adapter and system
|
|
JO3340B1
(ar)
*
|
2010-05-26 |
2019-03-13 |
Regeneron Pharma |
مضادات حيوية لـعامل تمايز النمو 8 البشري
|
|
ES2545411T5
(es)
|
2010-06-07 |
2024-04-05 |
Amgen Inc |
Dispositivo de administración de fármaco
|
|
PH12013500315A1
(en)
|
2010-08-16 |
2013-04-29 |
Amgen Inc |
Antibodies that bind myostatin, compositions and methods
|
|
WO2012135315A1
(en)
|
2011-03-31 |
2012-10-04 |
Amgen Inc. |
Vial adapter and system
|
|
LT2699293T
(lt)
|
2011-04-20 |
2019-04-25 |
Amgen Inc. |
Automatinio purškimo prietaisas
|
|
WO2012153337A2
(en)
*
|
2011-05-11 |
2012-11-15 |
Technion Research & Development Foundation Ltd. |
Anti-microbial peptides and uses of same
|
|
EP3045187B1
(en)
|
2011-10-14 |
2019-04-10 |
Amgen Inc. |
Injector and method of assembly
|
|
AU2012328753A1
(en)
|
2011-10-26 |
2014-04-24 |
Amgen Inc. |
Methods of reducing or eliminating protein modification and degradation arising from exposure to UV light
|
|
FR2982860B1
(fr)
*
|
2011-11-18 |
2015-07-10 |
Ass Fr Contre Les Myopathies |
Utilisation de la fibromoduline et du lumican pour augmenter la masse musculaire
|
|
CA2868469A1
(en)
|
2012-03-26 |
2013-10-03 |
Pronutria, Inc. |
Nutritive fragments, proteins and methods
|
|
SG11201405841RA
(en)
|
2012-03-26 |
2014-10-30 |
Pronutria Inc |
Nutritive fragments, proteins and methods
|
|
HK1206764A1
(en)
|
2012-03-26 |
2016-01-15 |
Axcella Health Inc. |
Nutritive proteins and methods
|
|
EP2831098A4
(en)
|
2012-03-26 |
2016-12-07 |
Axcella Health Inc |
LOADED NUTRIENT PROTEINS AND METHODS
|
|
AU2013204740C1
(en)
|
2012-05-10 |
2015-10-01 |
Agriculture Victoria Services Pty Ltd |
Methods of treating cancer using angiogenin or an angiogenin agonist
|
|
EP4678239A3
(en)
|
2012-08-01 |
2026-04-08 |
Ikaika Therapeutics, Inc. |
Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4)
|
|
JP2015535464A
(ja)
|
2012-11-21 |
2015-12-14 |
アムジエン・インコーポレーテツド |
薬剤送達装置
|
|
WO2014119753A1
(ja)
*
|
2013-01-31 |
2014-08-07 |
学校法人 東京薬科大学 |
マイオスタチン阻害ペプチド
|
|
KR20150136061A
(ko)
|
2013-02-01 |
2015-12-04 |
산타 마리아 바이오테라퓨틱스, 인코포레이티드 |
대상에 항-액티빈-a 화합물의 투여
|
|
US10492990B2
(en)
|
2013-03-15 |
2019-12-03 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
|
US10092703B2
(en)
|
2013-03-15 |
2018-10-09 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
|
TWI592183B
(zh)
|
2013-03-15 |
2017-07-21 |
安美基公司 |
本體輪廓可調適之自動注射器裝置
|
|
ES2853748T3
(es)
|
2013-03-22 |
2021-09-17 |
Amgen Inc |
Inyector y método de montaje
|
|
KR101523065B1
(ko)
*
|
2013-06-19 |
2015-05-27 |
한국기초과학지원연구원 |
입자크기가 제어된 금 나노입자의 제조방법 및 제조된 금 나노입자를 이용한 비색식 강산 검출방법
|
|
TW201601741A
(zh)
*
|
2013-09-09 |
2016-01-16 |
品特生物療法有限公司 |
用於治療ｅｓｒｄ病患之ｐｅｗ的肌肉生長抑制素拮抗劑
|
|
SG11201602012RA
(en)
|
2013-09-25 |
2016-04-28 |
Pronutria Inc |
Compositions and formulations for maintaining and increasing muscle mass, strength, and performance and methods of production and use thereof
|
|
EP3060275B1
(en)
|
2013-10-24 |
2019-07-03 |
Amgen Inc. |
Injector and method of assembly
|
|
MX2016005315A
(es)
|
2013-10-24 |
2016-08-11 |
Amgen Inc |
Sistema de administracion de farmacos con control sensible a la temperatura.
|
|
WO2015119906A1
(en)
|
2014-02-05 |
2015-08-13 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
|
SG11201609219QA
(en)
|
2014-05-07 |
2016-12-29 |
Amgen Inc |
Autoinjector with shock reducing elements
|
|
US20170103186A1
(en)
|
2014-06-03 |
2017-04-13 |
Amgen Inc. |
Systems and methods for supporting patient use of a drug delivery device
|
|
US9616114B1
(en)
|
2014-09-18 |
2017-04-11 |
David Gordon Bermudes |
Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
|
|
ES3056224T3
(en)
|
2014-10-14 |
2026-02-19 |
Amgen Inc |
Drug injection device with visual and audible indicators
|
|
WO2016073853A1
(en)
|
2014-11-06 |
2016-05-12 |
Scholar Rock, Inc. |
Anti-pro/latent-myostatin antibodies and uses thereof
|
|
US10799630B2
(en)
|
2014-12-19 |
2020-10-13 |
Amgen Inc. |
Drug delivery device with proximity sensor
|
|
EP3689394A1
(en)
|
2014-12-19 |
2020-08-05 |
Amgen Inc. |
Drug delivery device with live button or user interface field
|
|
US10583245B2
(en)
|
2015-02-17 |
2020-03-10 |
Amgen Inc. |
Drug delivery device with vacuum assisted securement and/or feedback
|
|
ES2905870T3
(es)
|
2015-02-27 |
2022-04-12 |
Amgen Inc |
Dispositivo de suministro de fármacos que tiene un mecanismo de protección de aguja con un umbral de resistencia ajustable al movimiento de la protección de aguja
|
|
US11268107B2
(en)
|
2015-04-23 |
2022-03-08 |
Washington State University |
SMAD7 gene delivery into muscle cells
|
|
CN106191215B
(zh)
|
2015-04-29 |
2020-03-24 |
中国科学院上海生命科学研究院 |
肌肉萎缩相关的蛋白质分子标记Dkk-3的筛选及其应用
|
|
US10676723B2
(en)
|
2015-05-11 |
2020-06-09 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
ES2964640T3
(es)
|
2015-08-13 |
2024-04-08 |
Amgen Inc |
Filtración en profundidad cargada de proteínas de unión al antígeno
|
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
|
EA038146B1
(ru)
|
2015-09-15 |
2021-07-13 |
Сколар Рок, Инк. |
Антитела к про-/латентному миостатину и их применения
|
|
JP7082568B2
(ja)
|
2015-12-09 |
2022-06-08 |
アムジエン・インコーポレーテツド |
信号伝達キャップ付き自動注射器
|
|
WO2017120178A1
(en)
|
2016-01-06 |
2017-07-13 |
Amgen Inc. |
Auto-injector with signaling electronics
|
|
CN115814077A
(zh)
|
2016-01-08 |
2023-03-21 |
供石公司 |
抗-原肌生长抑制素/潜伏肌生长抑制素抗体及其使用方法
|
|
WO2017160799A1
(en)
|
2016-03-15 |
2017-09-21 |
Amgen Inc. |
Reducing probability of glass breakage in drug delivery devices
|
|
RU2613420C1
(ru)
*
|
2016-04-13 |
2017-03-16 |
Сергей Михайлович Юдин |
Рекомбинантный белок Мио-ГСД, способ его получения, инъекционный препарат для повышения мышечной массы сельскохозяйственных животных, птицы и животных семейства псовых, а также способ использования препарата
|
|
EP3448414B1
(en)
*
|
2016-04-25 |
2024-04-17 |
Five Prime Therapeutics, Inc. |
Nope for treatment of pathological muscle loss and weakness
|
|
WO2017189089A1
(en)
|
2016-04-29 |
2017-11-02 |
Amgen Inc. |
Drug delivery device with messaging label
|
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
|
MX2018013616A
(es)
|
2016-05-13 |
2019-02-21 |
Amgen Inc |
Montaje de cubierta protectora de vial.
|
|
WO2017200989A1
(en)
|
2016-05-16 |
2017-11-23 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
|
ES3066292T3
(en)
|
2016-06-03 |
2026-05-12 |
Amgen Inc |
Impact testing apparatuses and methods for drug delivery devices
|
|
EP3478342B1
(en)
|
2016-07-01 |
2025-03-12 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
|
US10150115B2
(en)
*
|
2016-07-21 |
2018-12-11 |
Spacepharma SA |
System and method for rehydrating powder and delivering the rehydrated powder to a reactor
|
|
US20190328965A1
(en)
|
2016-08-17 |
2019-10-31 |
Amgen Inc. |
Drug delivery device with placement detection
|
|
ES3064802T3
(en)
|
2016-10-21 |
2026-04-29 |
Amgen Inc |
Pharmaceutical formulations and methods of making the same
|
|
EP3532127B1
(en)
|
2016-10-25 |
2026-04-08 |
Amgen Inc. |
On-body injector
|
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
|
HRP20230308T1
(hr)
*
|
2017-01-06 |
2023-05-12 |
Scholar Rock, Inc. |
Liječenje metaboličkih bolesti putem inhibiranja aktivacije miostatina
|
|
WO2018136398A1
(en)
|
2017-01-17 |
2018-07-26 |
Amgen Inc. |
Injection devices and related methods of use and assembly
|
|
AU2018220538B2
(en)
|
2017-02-17 |
2023-12-14 |
Amgen Inc. |
Drug delivery device with sterile fluid flowpath and related method of assembly
|
|
MX2019009755A
(es)
|
2017-02-17 |
2019-10-07 |
Amgen Inc |
Mecanismo de insercion para dispositivo de suministro de farmacos.
|
|
WO2018165143A1
(en)
|
2017-03-06 |
2018-09-13 |
Amgen Inc. |
Drug delivery device with activation prevention feature
|
|
KR102627069B1
(ko)
|
2017-03-07 |
2024-01-18 |
암겐 인코포레이티드 |
과압에 의한 바늘 삽입
|
|
SG11201908062QA
(en)
|
2017-03-09 |
2019-09-27 |
Amgen Inc |
Insertion mechanism for drug delivery device
|
|
MX2019011416A
(es)
|
2017-03-28 |
2019-11-01 |
Amgen Inc |
Sistema y metodo para conjunto de jeringa y vastago de embolo.
|
|
CA3066399A1
(en)
|
2017-06-08 |
2018-12-13 |
Amgen Inc. |
Torque driven drug delivery device
|
|
AU2018280054B2
(en)
|
2017-06-08 |
2023-07-13 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
|
MA49447A
(fr)
|
2017-06-22 |
2020-04-29 |
Amgen Inc |
Réduction des impacts/chocs d'activation d'un dispositif
|
|
JP7475860B2
(ja)
|
2017-06-23 |
2024-04-30 |
アムジエン・インコーポレーテツド |
スイッチアセンブリにより起動されるキャップを含む電子薬物送達デバイス
|
|
JP7408398B2
(ja)
|
2017-07-14 |
2024-01-05 |
アムジエン・インコーポレーテツド |
二重ねじりばねシステムを有する針挿入後退システム
|
|
JP7649105B2
(ja)
|
2017-07-21 |
2025-03-19 |
アムジエン・インコーポレーテツド |
薬物容器のためのガス透過性シーリング部材及び組立方法
|
|
WO2019022951A1
(en)
|
2017-07-25 |
2019-01-31 |
Amgen Inc. |
DRUG DELIVERY DEVICE WITH GEAR MODULE AND ASSEMBLY METHOD THEREOF
|
|
EP3658206A1
(en)
|
2017-07-25 |
2020-06-03 |
Amgen Inc. |
Drug delivery device with container access system and related method of assembly
|
|
US12318593B2
(en)
|
2017-08-09 |
2025-06-03 |
Amgen Inc. |
Hydraulic-pneumatic pressurized chamber drug delivery system
|
|
EP3668567B1
(en)
|
2017-08-18 |
2026-02-18 |
Amgen Inc. |
Wearable injector with sterile adhesive patch
|
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
|
EP3691717B1
(en)
|
2017-10-04 |
2023-02-08 |
Amgen Inc. |
Flow adapter for drug delivery device
|
|
EP4257164A3
(en)
|
2017-10-06 |
2024-01-17 |
Amgen Inc. |
Drug delivery device with interlock assembly and related method of assembly
|
|
MA50348A
(fr)
|
2017-10-09 |
2020-08-19 |
Amgen Inc |
Dispositif d'administration de médicament comprenant un ensemble d'entraînement et procédé d'assemblage associé
|
|
ES3069718T3
(en)
|
2017-11-03 |
2026-06-10 |
Amgen Inc |
System and approaches for sterilizing a drug delivery device
|
|
MA50569A
(fr)
|
2017-11-06 |
2020-09-16 |
Amgen Inc |
Ensembles de remplissage-finition et procédés associés
|
|
CA3079197A1
(en)
|
2017-11-06 |
2019-05-09 |
Amgen Inc. |
Drug delivery device with placement and flow sensing
|
|
IL319987A
(en)
|
2017-11-10 |
2025-06-01 |
Amgen Inc |
Plungers for drug delivery devices
|
|
AU2018368340B2
(en)
|
2017-11-16 |
2024-03-07 |
Amgen Inc. |
Door latch mechanism for drug delivery device
|
|
JP7747438B2
(ja)
|
2017-11-16 |
2025-10-01 |
アムジエン・インコーポレーテツド |
失速及び終点検出を有するオートインジェクタ
|
|
EP3569614A1
(en)
|
2018-05-18 |
2019-11-20 |
Julius-Maximilians-Universität Würzburg |
Compounds and methods for the immobilization of myostatin-inhibitors on the extracellular matrix by transglutaminase
|
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
|
KR102042352B1
(ko)
|
2018-07-16 |
2019-11-07 |
강릉원주대학교산학협력단 |
땅콩 껍질 추출물을 포함하는 근력강화 또는 근감소증의 예방 및 치료용 조성물
|
|
KR102259645B1
(ko)
|
2018-07-16 |
2021-06-02 |
강릉원주대학교산학협력단 |
구멍쇠미역 추출물을 포함하는 근력강화 또는 근감소증의 예방 및 치료용 조성물
|
|
CA3103682A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
|
US12303677B2
(en)
|
2018-07-24 |
2025-05-20 |
Amgen Inc. |
Hybrid drug delivery devices with optional grip portion and related method of preparation
|
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
|
CN112469454B
(zh)
|
2018-07-24 |
2024-01-26 |
安进公司 |
用于施用药物的输送装置
|
|
MA53320A
(fr)
|
2018-07-31 |
2021-11-03 |
Amgen Inc |
Ensemble de trajet de fluide pour dispositif d'administration de médicament
|
|
CA3106452A1
(en)
|
2018-09-24 |
2020-04-02 |
Amgen Inc. |
Interventional dosing systems and methods
|
|
US12042642B2
(en)
|
2018-09-28 |
2024-07-23 |
Amgen Inc. |
Muscle wire escapement activation assembly for a drug delivery device
|
|
WO2020072577A1
(en)
|
2018-10-02 |
2020-04-09 |
Amgen Inc. |
Injection systems for drug delivery with internal force transmission
|
|
JP7547325B2
(ja)
|
2018-10-05 |
2024-09-09 |
アムジエン・インコーポレーテツド |
投薬量インジケータを有する薬物送達デバイス
|
|
MA53913A
(fr)
|
2018-10-15 |
2022-01-19 |
Amgen Inc |
Procédé d'assemblage de plate-forme pour dispositif d'administration de médicament
|
|
JP7719714B2
(ja)
|
2018-10-15 |
2025-08-06 |
アムジエン・インコーポレーテツド |
ダンピング機構を有する薬物送達装置
|
|
DK3870957T3
(da)
|
2018-10-23 |
2025-09-29 |
Amgen Inc |
Automatisk kalibrering og automatisk vedligeholdelse af spectroskopiske modeller til realtidsprediktioner
|
|
WO2020091956A1
(en)
|
2018-11-01 |
2020-05-07 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
|
MA54057A
(fr)
|
2018-11-01 |
2022-02-09 |
Amgen Inc |
Dispositifs d'administration de médicament à rétraction partielle d'élément d'administration de médicament
|
|
AU2019406214A1
(en)
|
2018-12-21 |
2021-08-05 |
Northwestern University |
Use of annexins in preventing and treating muscle membrane injury
|
|
WO2020139977A1
(en)
|
2018-12-26 |
2020-07-02 |
Northwestern University |
Use of glucocorticoid steroids in preventing and treating conditions of muscle wasting, aging and metabolic disorder
|
|
EP3958934B1
(en)
|
2019-04-24 |
2025-04-09 |
Amgen Inc. |
Syringe sterilization verification assemblies and methods
|
|
US20220273887A1
(en)
|
2019-08-23 |
2022-09-01 |
Amgen Inc. |
Drug delivery device with configurable needle shield engagement components and related methods
|
|
WO2021158469A1
(en)
|
2020-02-03 |
2021-08-12 |
Amgen Inc. |
Multivariate bracketing approach for sterile filter validation
|
|
BR112023024278A2
(pt)
|
2021-05-21 |
2024-01-30 |
Amgen Inc |
Método de otimizar uma receita de enchimento para um recipiente de fármacos
|
|
WO2023076318A1
(en)
|
2021-10-27 |
2023-05-04 |
Amgen Inc. |
Deep learning-based prediction for monitoring of pharmaceuticals using spectroscopy
|
|
KR102726401B1
(ko)
*
|
2021-11-25 |
2024-11-05 |
(주)네오크레마 |
지방전구세포의 증식과 지방세포로의 분화를 억제하는 신규 펩티드 및 이의 용도
|
|
US20250082720A1
(en)
*
|
2021-11-25 |
2025-03-13 |
Neo Cremar Co., Ltd. |
New peptide and uses thereof
|
|
US20250090626A1
(en)
*
|
2021-11-25 |
2025-03-20 |
Neo Cremar Co., Ltd. |
New peptide and uses thereof
|
|
KR102726402B1
(ko)
*
|
2021-11-25 |
2024-11-05 |
(주)네오크레마 |
지방전구세포의 증식과 지방세포로의 분화를 억제하는 신규 펩티드 및 이의 용도
|
|
CN115403657A
(zh)
*
|
2022-06-23 |
2022-11-29 |
浙江大学 |
一种TGF-β3生长因子的亲和多肽及其应用
|
|
CN120677175A
(zh)
|
2022-12-22 |
2025-09-19 |
供石公司 |
肌生成抑制蛋白活化的选择性和强效抑制剂
|
|
WO2025037108A2
(en)
|
2023-08-15 |
2025-02-20 |
Board Of Trustees Of The Leland Stanford Junior University |
Modified thrombopoietin
|
|
WO2026030152A1
(en)
|
2024-07-29 |
2026-02-05 |
Amgen Inc. |
System and method for assessing transferability of a fill recipe
|